awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33399101-54D46E4C-0916-4390-A432-37399BA345A9
Q33399101-54D46E4C-0916-4390-A432-37399BA345A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399101-54D46E4C-0916-4390-A432-37399BA345A9
Spotlight on dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.
P2860
Q33399101-54D46E4C-0916-4390-A432-37399BA345A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33399101-54D46E4C-0916-4390-A432-37399BA345A9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5018e1e05affc3f4ede3898995c0c5a1cda217f8
P2860
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.